Literature DB >> 15112146

Geriatric assessment and comorbidity.

Arati V Rao1, Pearl H Seo, Harvey Jay Cohen.   

Abstract

Elderly persons, a rapidly growing population segment, have an increased incidence of cancer. The older cancer patient's clinical evaluation and treatment is influenced by conditions such as disabilities, comorbidity, and functional status, along with tumor type and stage. These conditions and other geriatric syndromes can be identified by comprehensive geriatric assessment to guide therapy and affect prognosis and quality of life. Comprehensive geriatric assessment involves the medical, functional, affective, social, spiritual, and environmental assessments. The medical assessment, which includes a nutrition, vision, hearing, continence, gait and balance, and cognition evaluation, can provide additional information to performance status and comorbidity. Although there are many assessment domains using several instruments, comprehensive geriatric assessment can be focused and efficient, especially with a multidisciplinary team of nurses, social workers, pharmacists, and other personnel. Comorbid illnesses may have complex interactions, with the underlying cancer influencing cancer diagnosis, disease course, treatment-related side effects, and mortality. Many instruments are available for comorbidity measurement, and retrospective studies in elderly cancer cohorts have shown comorbidity to influence survival. However, the ultimate aim would be to use comorbidity and comprehensive geriatric assessments prospectively in the older cancer patient to help predict the suitability and success of treatment with various antineoplastic modalities.

Entities:  

Mesh:

Year:  2004        PMID: 15112146     DOI: 10.1053/j.seminoncol.2003.12.026

Source DB:  PubMed          Journal:  Semin Oncol        ISSN: 0093-7754            Impact factor:   4.929


  9 in total

1.  Cancer in the elderly.

Authors:  A Hervás Morón
Journal:  Clin Transl Oncol       Date:  2007-10       Impact factor: 3.405

Review 2.  Systemic therapies for metastatic renal cell carcinoma in older adults.

Authors:  Sumanta K Pal; Ari Vanderwalde; Arti Hurria; Robert A Figlin
Journal:  Drugs Aging       Date:  2011-08-01       Impact factor: 3.923

3.  Comorbidities, functional limitations, and geriatric syndromes in relation to treatment and survival patterns among elders with colorectal cancer.

Authors:  Siran M Koroukian; Fang Xu; Paul M Bakaki; Mireya Diaz-Insua; Tanyanika Phillips Towe; Cynthia Owusu
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2009-12-16       Impact factor: 6.053

4.  Effects of cancer history on functional age and mortality.

Authors:  Cindy K Blair; David R Jacobs; Wendy Demark-Wahnefried; Harvey J Cohen; Miriam C Morey; Kim Robien; DeAnn Lazovich
Journal:  Cancer       Date:  2019-08-16       Impact factor: 6.860

5.  TREATMENT AND SURVIVAL PATTERNS IN RELATION TO MULTIMORBIDITY IN PATIENTS WITH LOCOREGIONAL BREAST AND COLORECTAL CANCER.

Authors:  Siran M Koroukian; Paul M Bakaki; Mark D Schluchter; Cynthia Owusu
Journal:  J Geriatr Oncol       Date:  2011-07       Impact factor: 3.599

Review 6.  Early breast cancer in the older woman.

Authors:  Ari VanderWalde; Arti Hurria
Journal:  Clin Geriatr Med       Date:  2011-11-23       Impact factor: 3.076

7.  The impact of age, performance status and comorbidities on nab-paclitaxel plus gemcitabine effectiveness in patients with metastatic pancreatic cancer.

Authors:  Martina Catalano; Giuseppe Aprile; Raffaele Conca; Roberto Petrioli; Monica Ramello; Giandomenico Roviello
Journal:  Sci Rep       Date:  2022-05-17       Impact factor: 4.996

8.  Using Geriatric Assessment to Guide Conversations Regarding Comorbidities Among Older Patients With Advanced Cancer.

Authors:  Amber S Kleckner; Megan Wells; Lee A Kehoe; Nikesha J Gilmore; Huiwen Xu; Allison Magnuson; Richard F Dunne; Marielle Jensen-Battaglia; Mostafa R Mohamed; Mark A O'Rourke; Nicholas J Vogelzang; Elie G Dib; Luke J Peppone; Supriya G Mohile
Journal:  JCO Oncol Pract       Date:  2021-07-06

9.  Influence of Comorbidities on the Efficacy of Radiotherapy with or without Chemotherapy in Elderly Stage III Non-small Cell Lung Cancer Patients.

Authors:  Joo Ho Lee; Hong-Gyun Wu; Hak Jae Kim; Dong-Wan Kim; Se-Hoon Lee; Tae Min Kim; Young Whan Kim; Dae Seog Heo
Journal:  Cancer Res Treat       Date:  2012-12-31       Impact factor: 4.679

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.